Home/Filings/4/0001209191-17-022296
4//SEC Filing

BIOCEPT INC 4

Accession 0001209191-17-022296

CIK 0001044378operating

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 4:16 PM ET

Size

7.9 KB

Accession

0001209191-17-022296

Insider Transaction Report

Form 4
Period: 2017-03-21
Nall Michael W.
DirectorCEO AND PRESIDENT
Transactions
  • Award

    Employee stock option (right to buy)

    2017-03-21+6,3336,333 total
    Exercise: $6.03From: 2017-03-21Exp: 2025-08-30Common Stock (6,333 underlying)
  • Award

    Employee stock option (right to buy)

    2017-03-21+10,00010,000 total
    Exercise: $4.02From: 2017-03-21Exp: 2026-02-28Common Stock (10,000 underlying)
Footnotes (2)
  • [F1]On August 31, 2015, the reporting person was granted an option to purchase shares of the Issuer's common stock that was to vest upon the achievement of corporate goals. On March 21, 2017, the Issuer's Board of Directors confirmed the achievement of such goals.
  • [F2]On February 29, 2016, the reporting person was granted an option to purchase shares of the Issuer's common stock that was to vest upon the achievement of corporate goals. On March 21, 2017, the Issuer's Board of Directors confirmed the achievement of such goals.

Issuer

BIOCEPT INC

CIK 0001044378

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001044378

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:16 PM ET
Size
7.9 KB